GlaxoSmithKline tipped to sell weight-loss drug

GlaxoSmithKline hopes to sell the world’s first officially approved over-the-counter weight-loss drug. The healthcare giant is seeking approval in the US to sell the drug, known as Orlistat, which is designed to limit fat absorption from food.